Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Wichmann C, Klotz DM, Zeiler HJ, Hilger RA, et al. The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its synergistic interaction with the PARP-inhibitor olaparib. Gynecol Oncol 2020 Sep 23. pii: S0090-8258(20)33911.
PMID: 32980128


Privacy Policy